
    
      Study Type: Interventional Study Design: Randomized, single dose, two-way crossover study
      under non-fasting conditions

      Official Title: A Relative Bioavailability Study of 160 mg Propranolol Hydrochloride Extended
      Release Capsules Under Non-Fasting Conditions

      Further study details as provided by Actavis Elizabeth LLC:

      Primary Outcome Measures:

      Rate and Extend of Absorption
    
  